Omar Khalid, Pharm D, MBA
About Omar Khalid, Pharm D, MBA
Omar Khalid, PharmD, MBA, is the Senior Director, Team Leader Regulatory Strategy Oncology at Bristol Myers Squibb in Princeton, New Jersey.
Title
Omar Khalid, Pharm D, MBA, currently holds the title of Senior Director, Team Leader Regulatory Strategy Oncology at Bristol Myers Squibb. He is stationed in Princeton, New Jersey, United States.
Current Role at Bristol Myers Squibb
Omar Khalid serves as the Senior Director, Team Leader Regulatory Strategy Oncology at Bristol Myers Squibb. In this role, he leads regulatory strategies for oncology products, ensuring compliance and facilitating global submissions for new therapies. His expertise encompasses various stages of drug development, from early phases to post-marketing activities.
Previous Roles at Bristol Myers Squibb
Before his current position, Omar Khalid held several key roles at Bristol Myers Squibb. He was the Director, Global Regulatory Lead Oncology Global Regulatory Sciences from 2020 to 2022, where he oversaw global regulatory activities for oncology products. Previously, he worked as the Associate Director, Global Regulatory Lead Oncology, Global Regulatory Sciences from 2018 to 2020 in the Greater New York City Area, contributing to regulatory submission planning and execution.
Past Experience at Biogen
Omar Khalid's extensive regulatory affairs career includes several positions at Biogen. He was the Associate Director Regulatory Affairs from 2017 to 2018 in Cambridge, Massachusetts. Prior to that, he served as Senior Manager Regulatory Affairs for three months in 2017 and as Manager Regulatory Affairs from 2016 to 2017 in the Greater Boston Area. His responsibilities included managing regulatory submissions and strategies for neurological and other therapies.
Education and Expertise
Omar Khalid earned his Doctor of Pharmacy (PharmD) and Master of Business Administration (M.B.A.) from St. John's University. He completed his PharmD between 2008 and 2014 and his MBA from 2014 to 2016. His educational background and extensive experience have equipped him with a deep understanding of global regulatory submissions, product development, strategy development, and submission planning and execution. He has worked across a wide range of therapeutic areas, including Oncology, Neurology, CNS, Gastroenterology, Cardiology, Immunology, Respiratory, Anti-Infective, Pain, Stroke, Multiple Sclerosis, and Hematology.
Previous Roles at Allergan and St. John's University
From 2014 to 2016, Omar Khalid worked as a Post Doctoral Fellow Global Regulatory Affairs at Allergan in Jersey City, New Jersey. He also served as an Adjunct Clinical Faculty at St. John's University during the same period. Earlier, he completed an internship in Medical Affairs at Allergan in 2013. These roles provided him with foundational experience in regulatory affairs and academia.